Suppr超能文献

1998年至2003年期间土耳其马尼萨社区获得性尿路感染大肠杆菌分离株中抗菌药物耐药性增加。

Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.

作者信息

Kurutepe Semra, Surucuoglu Suheyla, Sezgin Cenk, Gazi Horu, Gulay Mehmet, Ozbakkaloglu Beril

机构信息

Department of Microbiology and Clinical Microbiology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.

出版信息

Jpn J Infect Dis. 2005 Jun;58(3):159-61.

Abstract

Urinary tract infections are among the most common infections with an increasing resistance to antimicrobials. The aim of this study was to determine the change in antimicrobial susceptibility of Escherichia coli isolates from patients with community-acquired urinary tract infection (UTI) for the years 1998 through 2003 and to suggest that the current empirical antibiotic therapy used for these patients is inappropriate. During the study period, 7,335 community urine samples of which 1,203 (16.4%) grew bacterial isolates were analyzed. Among the total of 1,203 isolates, 880 (73.2%) were E. coli. The range of resistance of E. coli to ampicillin was 47.8 to 64.6% and that to trimethoprim-sulfamethoxazole was 37.1 to 44.6% during the study period. The susceptibility pattern of E. coli to nitrofurantoin and cefuroxime did not vary significantly over the 6-year period. There was a significant increase in the susceptibility of E. coli to ciprofloxacin (11.3 - 26.7%), amoxicillin-clavulanate (18.4 - 29.2%) and gentamicin (7.0 - 25.6%) (P < 0.05). Empirical initial treatment with ampicillin and trimethoprim-sulfamethoxazole was thus inadequate in approximately half of UTI cases in our region.

摘要

尿路感染是最常见的感染之一,且对抗菌药物的耐药性不断增加。本研究的目的是确定1998年至2003年期间社区获得性尿路感染(UTI)患者分离出的大肠杆菌对抗菌药物敏感性的变化,并表明目前用于这些患者的经验性抗生素治疗是不合适的。在研究期间,分析了7335份社区尿液样本,其中1203份(16.4%)培养出细菌分离株。在总共1203株分离株中,880株(73.2%)为大肠杆菌。在研究期间,大肠杆菌对氨苄西林的耐药率为47.8%至64.6%,对甲氧苄啶-磺胺甲恶唑的耐药率为37.1%至44.6%。在这6年期间,大肠杆菌对呋喃妥因和头孢呋辛的敏感性模式没有显著变化。大肠杆菌对环丙沙星(11.3%-26.7%)、阿莫西林-克拉维酸(18.4%-29.2%)和庆大霉素(7.0%-25.6%)的敏感性显著增加(P<0.05)。因此,在我们地区,大约一半的UTI病例采用氨苄西林和甲氧苄啶-磺胺甲恶唑进行经验性初始治疗是不足的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验